Literature DB >> 16940043

TAK1 is indispensable for development of T cells and prevention of colitis by the generation of regulatory T cells.

Shintaro Sato1, Hideki Sanjo, Tohru Tsujimura, Jun Ninomiya-Tsuji, Masahiro Yamamoto, Taro Kawai, Osamu Takeuchi, Shizuo Akira.   

Abstract

Transforming growth factor (TGF)-beta-activating kinase 1 (TAK1) is critical for Toll-like receptor- and tumor necrosis factor-mediated cellular responses. In B cells, TAK1 is essential for the activation of mitogen-activated protein kinases (MAPKs), but not nuclear factor-kappaB (NF-kappaB), in antigen receptor signaling. In this study, we generate T cell-specific TAK1-deficient (Lck(Cre/(+))Tak1(flox/flox)) mice and show that TAK1 is indispensable for the maintenance of peripheral CD4 and CD8 T cells. In thymocytes, TAK1 is essential for TCR-mediated activation of both NF-kappaB and MAPKs. Additionally, Lck(Cre/(+))Tak1(flox/flox) mice developed colitis as they aged. In these mice, accumulations of activated/memory T cells as well as B cells were observed. Development of regulatory T (Treg) cells in thymus was abrogated in Lck(Cre/(+))Tak1(flox/flox) mice, suggesting that the loss of Treg cells is the cause of the disease. Together, the results show that TAK1, by controlling the generation of central Treg cells, is important for preventing spontaneously developing colitis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16940043     DOI: 10.1093/intimm/dxl082

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  66 in total

Review 1.  Tenuous paths in unexplored territory: From T cell receptor signaling to effector gene expression during thymocyte selection.

Authors:  Lie Wang; Yumei Xiong; Rémy Bosselut
Journal:  Semin Immunol       Date:  2010-10       Impact factor: 11.130

Review 2.  Roles of the NF-kappaB pathway in lymphocyte development and function.

Authors:  Steve Gerondakis; Ulrich Siebenlist
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-12-23       Impact factor: 10.005

Review 3.  NF-κB signaling pathways regulated by CARMA family of scaffold proteins.

Authors:  Marzenna Blonska; Xin Lin
Journal:  Cell Res       Date:  2010-12-28       Impact factor: 25.617

4.  Transforming growth factor beta-activated kinase 1 (TAK1)-dependent checkpoint in the survival of dendritic cells promotes immune homeostasis and function.

Authors:  Yanyan Wang; Gonghua Huang; Peter Vogel; Geoffrey Neale; Boris Reizis; Hongbo Chi
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-23       Impact factor: 11.205

Review 5.  Ubiquitylation in innate and adaptive immunity.

Authors:  Vijay G Bhoj; Zhijian J Chen
Journal:  Nature       Date:  2009-03-26       Impact factor: 49.962

Review 6.  NF-κB control of T cell development.

Authors:  Steve Gerondakis; Thomas S Fulford; Nicole L Messina; Raelene J Grumont
Journal:  Nat Immunol       Date:  2014-01       Impact factor: 25.606

7.  Necroptosis in spontaneously-mutated hematopoietic cells induces autoimmune bone marrow failure in mice.

Authors:  Junping Xin; Peter Breslin; Wei Wei; Jing Li; Rafael Gutierrez; Joseph Cannova; Allen Ni; Grace Ng; Rachel Schmidt; Haiyan Chen; Vamsi Parini; Paul C Kuo; Ameet R Kini; Patrick Stiff; Jiang Zhu; Jiwang Zhang
Journal:  Haematologica       Date:  2016-09-15       Impact factor: 9.941

Review 8.  Foxp3+ regulatory T cells: differentiation, specification, subphenotypes.

Authors:  Markus Feuerer; Jonathan A Hill; Diane Mathis; Christophe Benoist
Journal:  Nat Immunol       Date:  2009-07       Impact factor: 25.606

Review 9.  CARMA1-mediated NF-kappaB and JNK activation in lymphocytes.

Authors:  Marzenna Blonska; Xin Lin
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

10.  Inflammatory mediator TAK1 regulates hair follicle morphogenesis and anagen induction shown by using keratinocyte-specific TAK1-deficient mice.

Authors:  Koji Sayama; Kentaro Kajiya; Koji Sugawara; Shintaro Sato; Satoshi Hirakawa; Yuji Shirakata; Yasushi Hanakawa; Xiuju Dai; Yumiko Ishimatsu-Tsuji; Daniel Metzger; Pierre Chambon; Shizuo Akira; Ralf Paus; Jiro Kishimoto; Koji Hashimoto
Journal:  PLoS One       Date:  2010-06-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.